30021520

HS code 30021520 (Chapter 30 "Pharmaceutical products"; Heading 3002 "Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and ether similar products; cell cultures, whether or not modified"; Subheading 300215 "Immunological products, put up in measured doses or in forms or packings for retail sale") under the Brazil tariff schedule classifies "Basiliximab (DCI); bevacizumab (DCI); daclizumab (DCI); etanercept (DCI); gemtuzumab ozogamicin (DCI); oprelvekin (DCI); rituximab (DCI); trastuzumab (DCI)". Brazil customs apply Import duty (II) of 0.0%, IPI 0.0%. This commodity is subject to 1 import regulation or restriction; see compliance section below.